We are live on ! Find out more
PTCT icon

PTC Therapeutics
PTCT

118 hedge funds and large institutions have $202M invested in PTC Therapeutics in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more call options, than puts

Call options by funds: $4.23M | Put options by funds: $1.99M

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

7% more capital invested

Capital invested by funds: $189M → $202M (+$13M)

0% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 22

1% less funds holding

Funds holding: 119 → 118 (-1)

Holders
118
Holders Change
-1
Holders Change %
-0.84%
% of All Funds
3.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
44
Reduced
33
Closed
22
Calls
$4.23M
Puts
$1.99M
Net Calls
+$2.24M
Net Calls Change
+$739K

Top Buyers

1
PAMU
Pictet Asset Management (UK)
United Kingdom
+$7.5M
2
CCM
Camber Capital Management
Massachusetts
+$4.45M
3
FCM
Frontier Capital Management
Massachusetts
+$3.42M
4
ACM
Asymmetry Capital Management
California
+$2.25M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.98M

Top Sellers

1
SAM
Sectoral Asset Management
Quebec, Canada
-$14.4M
2
Renaissance Technologies
Renaissance Technologies
New York
-$6.21M
3
Millennium Management
Millennium Management
New York
-$3.68M
4
SIM
Spark Investment Management
New York
-$1.76M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Teacher Retirement System of Texas
101
Teacher Retirement System of Texas
Texas
$30K +$4.61K +629 +17%
JCM
102
Jacobi Capital Management
Pennsylvania
$21K +$22K +3,000 New
BNP Paribas Financial Markets
103
BNP Paribas Financial Markets
France
$8.4K +$8.78K +1,197 New
Creative Planning
104
Creative Planning
Kansas
$8K -$5.13K -700 -39%
PAM
105
Panagora Asset Management
Massachusetts
$7K – – –
TRCT
106
Tower Research Capital (TRC)
New York
$6K +$5.13K +700 +350%
AF
107
Allworth Financial
California
$6K +$6.6K +900 New
Zurich Cantonal Bank
108
Zurich Cantonal Bank
Switzerland
$5K – – –
BJ
109
BlackRock Japan
Japan
$4K – – –
LTFS
110
Ladenburg Thalmann Financial Services
Florida
$2K -$88 -12 -4%
AWMS
111
Advocacy Wealth Management Services
Georgia
$2K – – –
PNC Financial Services Group
112
PNC Financial Services Group
Pennsylvania
$1K -$51 -7 -3%
CAW
113
Cornerstone Advisors (Washington)
Washington
$1K – – –
LJHT
114
Laurie J. Hall Trustee
$1K +$440 +60 +100%
CA
115
Commerzbank Aktiengesellschaft
Germany
$158 +$165K +22,488 New
SIM
116
Spark Investment Management
New York
– -$1.76M -274,100 Closed
VAM
117
Visium Asset Management
New York
– -$1.32M -204,554 Closed
GC
118
Guggenheim Capital
Illinois
– -$1.07M -166,541 Closed
Citadel Advisors
119
Citadel Advisors
Florida
– -$1.1M -150,594 Closed
WRF
120
Waddell & Reed Financial
Kansas
– -$848K -131,684 Closed
Prudential Financial
121
Prudential Financial
New Jersey
– -$701K -108,850 Closed
BCM
122
Bridgeway Capital Management
Texas
– -$553K -85,800 Closed
AQR Capital Management
123
AQR Capital Management
Connecticut
– -$550K -85,397 Closed
NIT
124
NumerixS Investment Technologies
British Columbia, Canada
– -$481K -74,647 Closed
Squarepoint
125
Squarepoint
New York
– -$327K -50,800 Closed
2 3 4
5
6

PTCT Hedge Fund Activity: Q2 2016 in Review

118 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in PTC Therapeutics (PTCT) for Q2 2016, worth a combined $202M — up 6.9% from $189M a quarter earlier.

Fund positioning in PTCT was balanced in Q2 2016: 22 funds opened new positions, 22 closed out, 44 added to existing stakes and 33 trimmed.

The largest buyer was Pictet Asset Management (UK), adding an estimated $7.5M. The largest seller was Sectoral Asset Management, cutting an estimated $14.4M.

  • 118 institutional investors held PTC Therapeutics (PTCT) as of Q2 2016, down from 119 in Q1 2016.
  • Funds reported $202M of PTC Therapeutics stock for Q2 2016, up 6.9% quarter-over-quarter.
  • 22 funds opened new PTC Therapeutics positions in Q2 2016 and 22 closed out, a net change of 0 holders.
  • The largest PTC Therapeutics buyer in Q2 2016 was Pictet Asset Management (UK), an estimated $7.5M added.
  • The largest PTC Therapeutics seller in Q2 2016 was Sectoral Asset Management, an estimated $14.4M sold.

Based on aggregated 13F filings for Q2 2016.